Sandip S. Kapadia's Insider Trades & SAST Disclosures
Sandip S. Kapadia's most recent trade in Skyward Specialty Insurance Group Inc was a trade of 5,000 2023 IPO RSU Grant (3-Year) done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sandip S. Kapadia.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 5,000 | 5,000 | - | - | 2023 IPO RSU Grant (3-Year) | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 5,000 | 17,213 | - | - | Common Stock | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 2,937 | 13,308 | - | - | Common Stock | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 2,937 | 0 | - | - | 2022 LTIP - PSUs | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 50.24 per share. | 06 Mar 2025 | 1,866 | 15,347 | - | 50.2 | 93,748 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 50.24 per share. | 06 Mar 2025 | 1,095 | 12,213 | - | 50.2 | 55,013 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 1,520 | 1,520 | - | - | 2025 LTIP - PSUs | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 1,520 | 1,520 | - | - | 2025 LTIP - RSUs | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 1,520 | 1,520 | - | - | 2025 LTIP - PSUs | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 66,250 | 66,250 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 18,900 | 18,900 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 3,812 | 3,812 | - | 0 | Common Stock | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 3,812 | 11,438 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.01 per share. | 24 Jan 2025 | 2,037 | 1,775 | - | 38.0 | 77,426 | Common Stock |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.05 per share. | 24 Jan 2025 | 1,775 | 0 | - | 38.1 | 67,547 | Common Stock |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.18 per share. | 21 Jan 2025 | 25,000 | 0 | - | 40.2 | 1,004,598 | Common Stock |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2025 | 25,000 | 205,000 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.03 per share. | 21 Jan 2025 | 25,000 | 25,000 | - | 29.0 | 725,750 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 49.51 per share. | 02 Jan 2025 | 4,347 | 12,508 | - | 49.5 | 215,233 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 47.65 per share. | 02 Jan 2025 | 678 | 11,279 | - | 47.7 | 32,309 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 47.82 per share. | 02 Jan 2025 | 551 | 11,957 | - | 47.8 | 26,350 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 46.97 per share. | 02 Jan 2025 | 464 | 10,371 | - | 47.0 | 21,792 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Sale of securities on an exchange or to another person at price $ 46.99 per share. | 02 Jan 2025 | 444 | 10,835 | - | 47.0 | 20,864 | Common Stock |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 60,000 | 90,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 60,000 | 60,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.00 per share. | 30 Sep 2024 | 32,052 | 27,948 | - | 40 | 1,282,080 | Common Stock |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 47,693 | 47,693 | - | - | Director Stock Option (right to buy) | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2024 | 15,000 | 15,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2024 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.58 per share. | 29 Mar 2024 | 8,013 | 6,987 | - | 33.6 | 269,077 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,745 | 1,745 | - | - | 2024 LTIP - Performance Share Units | |
| Skyward Specialty Insuranc... | Kapadia Sandip | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,745 | 1,745 | - | - | 2024 LTIP - Common Stock | |
| Harmony Biosciences Holdin... | S. Sandip Kapadia | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 74,250 | 74,250 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Kapadia Sandip S. | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 15,250 | 15,250 | - | - | Restricted Stock Units | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 3,968 | 0 | - | - | Restricted Stock Unit | |
| Skyward Specialty Insuranc... | Kapadia Sandip | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 3,968 | 16,140 | - | - | Common Stock | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 1,394 | 0 | - | - | Restricted Stock Unit | |
| Skyward Specialty Insuranc... | Kapadia Sandip | EVP, CHIEF ACTUARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 1,394 | 12,172 | - | - | Common Stock | |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 30,000 | 30,000 | - | 0 | Common Stock | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2023 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Sandip S. Kapadia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.36 per share. | 29 Mar 2023 | 15,414 | 14,586 | - | 33.4 | 514,211 | Common Stock |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 2,020 | 2,020 | - | - | 2023 LTIP - Performance Share Units | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 2,020 | 2,020 | - | - | 2023 LTIP - Common Stock | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 40,000 | 40,000 | - | - | 2023 Stock Options (Right to Buy) | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 10,000 | 10,000 | - | - | 2023 RSU Grant (4-Year) | |
| Skyward Specialty Insuranc... | Sandip Kapadia | EVP, CHIEF ACTUARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 10,000 | 10,000 | - | - | 2023 RSU Grant (3-Year) | |
| Passage Bio Inc | Sandip S. Kapadia | Director | Sale of securities on an exchange or to another person at price $ 1.19 per share. | 01 Dec 2022 | 5,000 | 0 (0%) | 0% | 1.2 | 5,965 | Common Stock |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 24,000 | 24,000 | - | - | Director Stock Option (Right to Buy) | |
| Passage Bio Inc | Sandip S. Kapadia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 16,918 | 16,918 | - | - | Director Stock Option (Right to Buy) | |
| Intercept Pharmaceuticals Inc | Sandip S. Kapadia | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 26,900 | 26,900 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Sandip S. Kapadia | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 17,200 | 40,964 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Sandip S. Kapadia | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 32.78 per share. | 15 Dec 2020 | 1,763 | 27,158 (0%) | 0% | 32.8 | 57,791 | Common Stock |
| Intercept Pharmaceuticals Inc | Sandip S. Kapadia | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. | 01 Oct 2020 | 296 | 28,921 (0%) | 0% | 42.1 | 12,456 | Common Stock |
| Intercept Pharmaceuticals Inc | Sandip S. Kapadia | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. | 01 Jul 2020 | 615 | 29,217 (0%) | 0% | 46.5 | 28,610 | Common Stock |
| Intercept Pharmaceuticals Inc | Sandip S. Kapadia | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.40 per share. | 01 Apr 2020 | 615 | 29,832 (0%) | 0% | 58.4 | 35,916 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges